lundi 17 septembre 2018

Onco Actu du 17 septembre 2018


1. Biologie

Protein analysis uncovers new medulloblastoma subtypes [MIT News]

2. Etiologie

Children Who Develop Acute Lymphoblastic Leukemia May Have Dysregulated Immune Function At Birth [AACR]

3.1.1 Prévention - Tabac - e-cigs

Number of vapers tops 3 million for first time in Britain [Cancer Research UK]

U.S. health secretary backs proposed FDA crackdown on e-cigarettes [Reuters]

3.4.1 Chimioprévention - aspirine

Daily low-dose aspirin found to have no effect on healthy life span in older people [NIH]

Daily aspirin unlikely to help healthy older people live longer, study finds [The Guardian]

Low-Dose Aspirin Late in Life? Healthy People May Not Need It [NY Times]

5. Traitements

Making chemotherapy kinder for childhood leukaemia [Cancer Research UK]

5.10 Traitements - Essais

Europe’s academics fail to report results for 90% of clinical trials [Nature]

5.12.2 Immunothérapies - CAR-T, thérapies cellulaires

Putting Natural Killer Cells to the Test in Cancer Immunotherapy [Dan-Farber Cancer Institute]

Institut Curie announces creation of Honing Biosciences [Institut Curie]

5.3.4 Traitements - AMM (FDA, EMA,...)

Moxetumomab Approved by FDA for Hairy Cell Leukemia [NCI]

6. Lutte contre les cancers

Ten years after the economic crash, R&D funding is better than ever [Nature]

6.1 Observation

For Elderly Women With Breast Cancer, Surgery May Not Be the Best Option [NY Times]

6.11 Patients

2-Year-Old Boy With Deadly Cancer Gets an Early Christmas From His Neighbors [NY Times]

6.12 Ethique

José Baselga resigns from MSK over disclosure controversy [FierceBiotech]

Bristol-Myers Squibb Statement on Resignation of Dr. José Baselga [BMS]

Why do medical journals keep taking authors at their word? [STAT]

6.2 Implants mammaires

Statement from Binita Ashar, M.D., of the FDA’s Center for Devices and Radiological Health on agency’s commitment to studying breast implant safety [FDA]

6.3 Associations/Fondations

Mark Zuckerberg is selling up to $13 billion of Facebook stock to fund an ambitious project to end disease: Here's an early look inside [CNBC]

6.6 Publications

Not all academics are comfortable with the idea of open peer review [LSE Impact Blog]

NEJM doubles down on refusal to retract article Dartmouth says is plagiarized [STAT]

6.9 Controverses

Turmoil erupts over expulsion of member from leading evidence-based medicine group [STAT]

Evidence-based medicine group in turmoil after expulsion of co-founder [Science]